Showing 281 - 300 results of 100,948 for search '(( 10 men decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.39s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289

    Possible Points of Canonical Wnt Inhibition. by Laura Corbett (826084)

    Published 2015
    “…<p>This study has highlighted six possible points of canonical Wnt inhibition occurring in HSCs. (1) Predominantly non-canonical ligand expression. …”
  10. 290
  11. 291

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…After 4 weeks, when the tumor size was approximately 100 mm<sup>3</sup> (T<sub>0</sub>) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”
  12. 292
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297

    Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

    Published 2023
    “…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”
  18. 298
  19. 299
  20. 300

    Lifetime risk of developing type 2 diabetes, for cohorts of 25 years-old individuals according to scenarios. by Pierre Bauvin (18154818)

    Published 2024
    “…<p>Initial weight distribution is representative of the one of the 25 years-old individuals in 2022: A) men, 73.2% normal weight, 17.9% overweight, 6.6% obese class I, 1.9% obese class II, 0.5% obese class III, and B) women, 81.0% normal weight, 9.7% overweight, 5.4% obese class I, 2.6% obese class II, 1.3% obese class III. …”